Top Premarket Gainers

Published on 06/06/2025 at 07:40

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Applied DNA Sciences, Inc.

Applied DNA Sciences Receives Nasdaq Compliance Notice	Jul. 07	MT
Applied DNA Sciences, Inc. Ceases Operations At Applied DNA Clinical Labs and Workforce Reduction	Jun. 30	CI
Applied DNA Sciences Reducing Workforce by 27% in Strategic Shift	Jun. 30	MT
Applied DNA Sciences, Inc. Announces CEO Changes	Jun. 17	CI
Applied DNA Sciences, Inc. Announces Board Changes	Jun. 17	CI
Top Premarket Gainers	Jun. 06	MT
Applied DNA Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025	May. 15	CI
Applied DNA Sciences Regains Nasdaq Compliance on Minimum Bid Price Rule	Apr. 08	MT
Applied DNA Seeks New York Approval for H5 Bird Flu Test	Mar. 26	MT
Applied DNA Sciences to Implement 1-for-50 Reverse Stock Split; Shares Fall	Mar. 12	MT
Applied DNA Sciences Says 1-For-50 Reverse Stock Split Of Issued And Outstanding Common Stock Effective March 14	Mar. 12	RE
Applied DNA Sciences, Inc., Q1 2025 Earnings Call, Feb 13, 2025	Feb. 13
Applied DNA Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2024	Feb. 13	CI
Applied DNA Sciences, Inc. Completes Buildout of GMP Facility for LineaDNA IVT Templates	Jan. 10	CI
Applied DNA Sciences, Inc. Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA	Dec. 18	CI
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q4 Revenue $813,106, vs. Street Est of $0.9M	Dec. 17	MT
Applied DNA Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2024	Dec. 17	CI
Applied DNA Sciences, Inc. Auditor Raises 'Going Concern' Doubt	Dec. 16	CI
APDN Files for Resale of 41.6 Million Shares by Selling Stockholders	Nov. 19	MT
Applied DNA Sciences, Inc. announced that it has received funding	24-10-30	CI
Applied DNA Sciences, Inc. announced a financing transaction	24-10-29	CI
Applied DNA Regains Nasdaq Compliance With Minimum Bid Price Rule	24-09-18	MT
Applied DNA Sciences, Inc. Receives Linea DNA Follow-On Order from Global Manufacturer of IVDs for Cancer Diagnostic Application	24-09-17	CI
Sector Update: Health Care Stocks Retreat Late Afternoon	24-09-11	MT
Sector Update: Health Care Stocks Softer in Afternoon Trading	24-09-11	MT